University of Crete (UOC)
Εγγενής ανοσία και κλινική έκβαση της λοίμωξης από τον ιό της ηπατίτιδας Β στα παιδιά
Abstract
dc:descriptionHepatitis B virus infection in childhood remains a consirable health problem worldwide,even after the introduction of passive and active immunoprophylaxis for children born toHBV positive mothers. The great majority (90%) of newborns that will acquire HBVduring their perinatal period and a significant percentage (30%) of children that will acquireHBV infection during their first 6 years of life will develop chronic infection, compared toa lesser degree (10%) of adults. The risk of HBV transmission from an HBsAg positivemother to her infant is associated with different factors including the timing of exposure,the maternal HBeAg carriage associated with significant infectivity and the viral load atbirth.The contribution of genetic factors to the outcome of ΗΒV infection is shown in recentgenetic association studies. Mannose binding lectin (MBL) is an innate immunity factorknown to activate the complement after binding to HBV surface glycoproteins and to elicit viral opsonisation. Variants in mbl2 gene, including the single point mutations in exon 1(codons 54 and 57) and at position 221 of the promoter reduce plasma MBL levels. MBLdeficiency has been related to increased susceptibility to infections in infants and pooroutcome of hepatitis B and C in adults.Tumor necrosis factor alpha (TNF-α) is also an efficient factor of HBV clearance, able todisrupt viral particles, transcriptional templates and episomal covalently closed circularDNA. Plasma TNF-α level is modified by a variant at position −308 of its gene. Vitamin Daffects viral presentation by suppressing antigen presentation and effector T cells activationin a vitamin D receptor (VDR) transcription-dependent way. Low level of viral antigens,expressed by antigen presenting cells, are unable to induce the CD4 T cells but sufficient to activate cytotoxic T cells, which mediate liver injury without clearing HBV. Two variantsin the VDR gene, ApaI A/a at intron 8 and TaqI T/t at exon 9, have already been related tothe outcome of hepatitis B in adults.The effect of the mbl2 (Cdn54 GGC to GAC, Cdn57 GGA to GAA, -221 G to C), TNF-α (-308 A to G) and VDR gene (ApaI G toT, TaqI T to C) variants on the acquisition of HBVinfection and the outcome of infection (progress to chronicity or clearance) was studied on102 children and adolescents (53 male and 49 female), aged 0.5 to 18.5 years (mean age9.17 years), who were born to HBV positive mothers and had not receivedimmunoprophylaxis. The children were assessed for HBV serology and those found to beHBsAg positive were retested later for potential HBsAg seroconversion. The group ofchronic HBV infection (presence of HbsAg for more than 6 months) consisted of 33HBsAg positive children, 14 male and 19 female, aged 3.0 to 18.5 (mean 11.4) years. Thegroup of spontaneous HBV clearance (disappearance of HbsAg and the development of anti-Hbs antibodies) consisted of 36 children, 17 male and 19 female, aged 0.5 to 18 (mean9.47) years and the group of naïve subjects consisted of 33 children, 22 male and 11female, aged 1.0 to 14 (mean 6.58) years. Initially genomic DNA was isolated from wholeblood, followed by polymerase chain reaction (PCR), restriction fragment lengthpolymorphism (RFLP) methods and electrophoresis in agarose gels. MBL serum levelswere determined in 28, 32, and 16 children with HBV chronic infection, clearance andnaivety, respectively by indirect enzyme-linked immunosorbent assay (ELISA). MBLlevels were defined as low when <500 and normal when >500 ng/ml. The allele, genotype, haplotype frequencies and MBL levels were compared among thegroups with Fisher’s exact probability test and risk ratios (RR) and 95% confidenceintervals (CI) were calculated. The following differences were observed:Females were at higher risk of acquiring HBV infection than males (p=0.032), but not at adifferent risk of progressing to chronicity (p=0.44).The prevalence of mutant alleles in codons 54 and 57 and at position -221 and thedistribution of mbl2 haplotypes did not differ among the study groups. Low serum MBLvalues were found in 13.2% of the whole cohort, in 10.7% of children with chronicinfection, 15.6% of children with HBV clearance and 12.5% of HBV naïve subjects. MBLdeficiency as defined by mbl2 genotypes or MBL serum levels was not shown to havesignificant impact in early HBV infection.TNF-alpha-308 G allele was found more frequently in children with chronic infection thanin HBV naïve children (p=0.050) and in infected than non-infected children, though not at asignificant level (p 0.089).VDR ApaI A allele (as compared to a allele) was more frequent, though at a marginal levelof significance, in children with chronic than in children with resolved infection (p=0.071).On the other hand, VDR ApaI α allele in VDR ApaI and TaqI joint haplotype αΤ (ascompared to At and AT haplotypes) was more frequent in children with resolved than inchildren with chronic infection (p=0.049). TaqI and ApaI markers were found to be inlinkage disequilibrium, consistently with the findings of previous studies. Three jointgenotypes (AAtt, AaTt, aaTT) were more common exhibiting frequencies of 22.5%, 39.2%and 17.6% compared to the less common genotypes AATt, AATT, AaTT (9.8%, 2.9% and7.8%, respectively). Our findings suggest that TNF-alpha and possibly vitamin D pathways may be involved inthe progress of early HBV infection. The present study as all genetic association studiesprovide a better understanding of HBV infection pathogenesis early in life. Future globalmulticohort studies that will include multiple genetic variations, haplotypes and clinicaldata are required for the clarification of HBV immunogenetics. Polymorphisms may serveas genetic markers and facilitate the estimation of long-term outcome. Genetic studies raisehopes of the emergence of automated, rapid and affordable tools in the diagnostics andmanagement of hepatitis B.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzidaki, Virginia
- Χατζηδάκη, Βιργινία
Subjects
dc:subject × 20- HBV λοίμωξη
- Κάθετη μετάδοση
- Γενετικοί πολυμορφισμοί
- Έμφυτη ανοσία
- Συνδεόμενη στη μαννόζη λεκτίνη
- Παράγοντες νέκρωσης όγκου (TNF-α)
- Υποδοχές της βιταμίνης D (VDR)
- HBV infection
- Mother to child transmission
- Gene polymorphisms
- Innate immunity
- Mannose binding lectin (MBL)
- Tumor necrosis factor (TNF)
- Vitamin D receptor
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38005